SG153837A1 - Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 - Google Patents
Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52Info
- Publication number
- SG153837A1 SG153837A1 SG200904200-3A SG2009042003A SG153837A1 SG 153837 A1 SG153837 A1 SG 153837A1 SG 2009042003 A SG2009042003 A SG 2009042003A SG 153837 A1 SG153837 A1 SG 153837A1
- Authority
- SG
- Singapore
- Prior art keywords
- hpv
- hpv18
- vaccine against
- another
- type selected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0413510.9A GB0413510D0 (en) | 2004-06-16 | 2004-06-16 | Vaccine |
US11/114,301 US20050287161A1 (en) | 2002-12-20 | 2005-04-26 | Vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
SG153837A1 true SG153837A1 (en) | 2009-07-29 |
Family
ID=35160037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200904200-3A SG153837A1 (en) | 2004-06-16 | 2005-06-14 | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1758609B1 (xx) |
JP (1) | JP2008502633A (xx) |
KR (1) | KR20070029254A (xx) |
AR (1) | AR049354A1 (xx) |
AU (1) | AU2005253723B2 (xx) |
BR (1) | BRPI0512042B8 (xx) |
CA (1) | CA2566620C (xx) |
FR (2) | FR15C0082I2 (xx) |
IL (1) | IL179138A0 (xx) |
LU (3) | LU92900I2 (xx) |
MA (1) | MA28692B1 (xx) |
MX (1) | MXPA06014515A (xx) |
NO (1) | NO20070195L (xx) |
PE (1) | PE20060434A1 (xx) |
PL (1) | PL1758609T3 (xx) |
RU (1) | RU2420313C2 (xx) |
SG (1) | SG153837A1 (xx) |
WO (1) | WO2005123125A1 (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008539182A (ja) * | 2005-04-26 | 2008-11-13 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
CA2732436C (en) * | 2008-07-31 | 2018-01-16 | Glaxosmithkline Biologicals S.A. | Vaccine against hpv |
EP2444103B1 (en) * | 2009-06-19 | 2017-12-20 | Eyegene Inc. | Vaccine for cervical cancer |
WO2012006727A1 (en) * | 2010-07-15 | 2012-01-19 | British Columbia Cancer Agency Branch | Human papillomavirus e7 antigen compositions and uses thereof |
BR112015008930A2 (pt) | 2012-10-30 | 2017-11-21 | Redvax Gmbh | vacinas baseadas em partícula recombinante contra a infecção por citomegalovírus humano |
CN107001430A (zh) * | 2014-10-24 | 2017-08-01 | 哈普威克斯有限责任公司 | 癌症和皮肤病变治疗 |
CN107188966B (zh) | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | 一种乳头瘤病毒嵌合蛋白及其用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
GB9921147D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
US6908613B2 (en) * | 2000-06-21 | 2005-06-21 | Medimmune, Inc. | Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
GB0110431D0 (en) * | 2001-04-27 | 2001-06-20 | Glaxosmithkline Biolog Sa | Novel compounds |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206359D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
ATE503492T1 (de) * | 2002-12-20 | 2011-04-15 | Glaxosmithkline Biolog Sa | Verwendung von hpv16 und hpv18 vlps als vakzine gegen eine oder mehrere onkogene hpv des typus 31,33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 |
-
2005
- 2005-06-14 JP JP2007515878A patent/JP2008502633A/ja active Pending
- 2005-06-14 MX MXPA06014515A patent/MXPA06014515A/es active IP Right Grant
- 2005-06-14 PL PL05757953T patent/PL1758609T3/pl unknown
- 2005-06-14 RU RU2006143804/10A patent/RU2420313C2/ru active
- 2005-06-14 SG SG200904200-3A patent/SG153837A1/en unknown
- 2005-06-14 CA CA2566620A patent/CA2566620C/en active Active
- 2005-06-14 WO PCT/EP2005/006461 patent/WO2005123125A1/en active Application Filing
- 2005-06-14 KR KR1020077001065A patent/KR20070029254A/ko active Application Filing
- 2005-06-14 PE PE2005000677A patent/PE20060434A1/es not_active Application Discontinuation
- 2005-06-14 AR ARP050102434A patent/AR049354A1/es not_active Application Discontinuation
- 2005-06-14 EP EP05757953A patent/EP1758609B1/en active Active
- 2005-06-14 BR BRPI0512042A patent/BRPI0512042B8/pt active IP Right Grant
- 2005-06-14 AU AU2005253723A patent/AU2005253723B2/en active Active
-
2006
- 2006-11-09 IL IL179138A patent/IL179138A0/en unknown
- 2006-12-28 MA MA29576A patent/MA28692B1/fr unknown
-
2007
- 2007-01-11 NO NO20070195A patent/NO20070195L/no not_active Application Discontinuation
-
2015
- 2015-12-04 FR FR15C0082C patent/FR15C0082I2/fr active Active
- 2015-12-04 FR FR15C0084C patent/FR15C0084I2/fr active Active
- 2015-12-08 LU LU92900C patent/LU92900I2/xx unknown
- 2015-12-08 LU LU92898C patent/LU92898I2/xx unknown
- 2015-12-08 LU LU92899C patent/LU92899I2/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL179138A0 (en) | 2007-03-08 |
CA2566620C (en) | 2014-03-11 |
BRPI0512042B1 (pt) | 2019-01-22 |
NO20070195L (no) | 2007-01-15 |
BRPI0512042B8 (pt) | 2021-05-25 |
RU2420313C2 (ru) | 2011-06-10 |
BRPI0512042A (pt) | 2008-02-06 |
EP1758609A1 (en) | 2007-03-07 |
LU92900I2 (fr) | 2016-03-08 |
RU2006143804A (ru) | 2008-08-20 |
KR20070029254A (ko) | 2007-03-13 |
AU2005253723A1 (en) | 2005-12-29 |
CA2566620A1 (en) | 2005-12-29 |
FR15C0084I2 (fr) | 2016-10-28 |
FR15C0084I1 (xx) | 2016-01-08 |
LU92899I2 (fr) | 2016-03-08 |
LU92898I2 (fr) | 2016-03-08 |
FR15C0082I2 (fr) | 2016-10-28 |
WO2005123125A1 (en) | 2005-12-29 |
EP1758609B1 (en) | 2012-10-03 |
PL1758609T3 (pl) | 2013-02-28 |
AR049354A1 (es) | 2006-07-19 |
PE20060434A1 (es) | 2006-06-08 |
FR15C0082I1 (fr) | 2016-01-08 |
MXPA06014515A (es) | 2007-03-23 |
MA28692B1 (fr) | 2007-06-01 |
AU2005253723B2 (en) | 2011-01-20 |
JP2008502633A (ja) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4215543A3 (en) | Hpv-specific binding molecules | |
SG153837A1 (en) | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 | |
WO2007130327A3 (en) | Influenza virus-like particle (vlp) compositions | |
AP1872A (en) | Virus-like particles of human papillomavirus. | |
HK1085378A1 (en) | Use of hpv16 and hpv18 as vaccine against one or more of oncogenic hpv type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 | |
WO2006015035A8 (en) | Useful compounds for hpv infection | |
WO2007121894A3 (en) | Hpv-18-based papillomavirus vaccine | |
WO2007130330A3 (en) | Polyvalent influenza virus-like particle (vlp) compositions | |
BRPI0810959A2 (pt) | "proteína l1 do hpv11, polinucleotídeo, vetor, célula, composição, partícular semelhante ao vírus (vlp) hp11, método para produzir uma proteína l1 do hpv,vacina para prevenção de condiloma acuminado ou de infecções por hpv, uso da proteína método para prevenção de condiloma acuminado ou infecções por hpv e método para prevenção de condiloma acuminado ou infecções por hpv. | |
CY1113830T1 (el) | Εμβολιο εναντι hpv16 και hpv18 και τουλαχιστον ενος αλλου τυπου hpv ο οποιος επιλεγεται απο hpv 31,45 ή 52 | |
WO2007121895A3 (en) | Hpv-16-based papillomavirus vaccine | |
WO2008034388A8 (fr) | Particules virales de protéines de la capside provenant du papillomavirus humain de type 16/58/18/6/11 et leur procédé de préparation et leurs utilisations | |
EP2444103A4 (en) | VACCINE AGAINST NUTRITIONAL CANCER | |
MX2022009964A (es) | Vacuna contra hpv. | |
BRPI0810951B8 (pt) | proteína l1 do hpv6, polinucleotídeo, vetor, célula, partícula semelhante ao vírus (vlp) hpv6, método para produzir a proteína hpv6 l1 truncada, vacina para prevenção de condiloma acuminado ou de infecções por hpv, uso da proteína hpv6 l1 truncada, método para prevenção de condiloma acuminado ou infecções por hpv, método para obter uma vlp de uma proteína l1 do hpv6 e método para produzir uma vacina para a prevenção de condiloma acuminado ou de infecções por hpv | |
JP2006512413A5 (xx) | ||
WO2009053601A3 (fr) | Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant | |
EA201170264A1 (ru) | Вакцина против hpv | |
ATE380034T1 (de) | Neues verfahren zur herstellung von virus- ähnlichen partikeln des menschen-papillomavirus mit verbesserten eigenschaften | |
WO2012036437A3 (ko) | 면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련 질환 예방 또는 치료용 조성물 | |
MXPA02003328A (es) | Vacuna. | |
WO2004098497A3 (en) | Cd4+ human papillomavirus (hpv) epitopes | |
EA200702077A1 (ru) | Вакцина | |
MX2014000522A (es) | Composicion y metodo para tratar virus del papiloma humano (vph). | |
SI1572233T1 (sl) | Uporaba HPV16 in HPV18 kot cepivo proti enemu ali več onkogenih HPV tipa 31,33,35,39,45,51,52,56,58,59,66,68 |